Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma.

Clinical trial NCT00330759 · COMPLETED

Trial details

NCT number: NCT00330759
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Bone Metastases

Start date: 2006-06-01
Primary completion: 2009-04-01
Enrollment: 1779

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.